Medical/Pharmaceuticals

WuXi AppTec Wuhan Site Resumes Operation

SHANGHAI, March 11, 2020 /PRNewswire/ -- WuXi AppTec announced today that the company'sWuhan site has resumed operations, in compliance with local regulations and global COVID-19 health and safety guidelines. Operations at the Wuhan facility, which provides discovery chemistry services, will ramp ...

2020-03-11 20:00 1690

Concord Medical Welcomes RMB700 Million Investment

BEIJING, March 11, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, education and prevention by operating a network of medically advanced comprehensive cancer hospitals and...

2020-03-11 15:40 5660

CIMC-produced Mobile Cabins Put Into Use in Chinese Hospitals to Help Combat Coronavirus

SHENZHEN, China, March 9, 2020 /PRNewswire/ -- The first mobile CT scan cabin produced by Yangzhou Tailee Special Equipment Co Ltd (A member enterprise of CIMC) has been put into use in a hospital in Huanggang, one of the worst hit cities by the coronavirus outbreak inHubei province, to help with...

2020-03-10 09:30 1805

NDA Filing for Luye Pharma's Antidepressant Drug LY03005 Accepted by the U.S. FDA

SHANGHAI, March. 4, 2020 /PRNewswire/ -- Luye Pharma Group has announced that the U.S. Food and Drug Administration (FDA) has reviewed and accepted the filing of a New Drug Application (NDA) for LY03005, a new chemical drug for the treatment of major depressive disorder. LY03005 is the company's ...

2020-03-04 21:27 2105

China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results

BEIJING, March 3, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its fourth quarter and fiscal year 2019 fi...

2020-03-03 21:30 7814

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from c...

2020-03-03 03:00 1266

Yuyu Pharma announces review of compliance policies and procedures

SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...

2020-03-02 22:00 1223

China Pharmaceutical Holdings Co., Ltd. Launched A New Product

HAIKOU CITY, China, March 2, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its subsidiary, Hainan ...

2020-03-02 20:00 6032

3SBIO makes investment in MPM's $100M Oncology Innovations Fund and donation to Dana-Farber cancer research

SHANGHAI, March 1, 2020 /PRNewswire/ -- MPM Capital (MPM) and Dana-Farber Cancer Institute have jointly announced onFebruary 26, 2020 the successful closing of the MPM Oncology Innovations Fund (INV) with$100M in capital, and the Dana-Farber Innovations Research Fund (IRF) with more than$26M in p...

2020-03-01 16:30 1542

Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect

SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations. The company confi...

2020-02-27 15:49 1548

WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis

SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- WuXi Diagnostics has successfully developed a series of COVID-19 detection products, including2019-nCoV IgM Detection kit (Enzyme-linked Immunoassay, ELISA), 2019-nCoV IgM/IgG Detection Kit (Enzyme-linked Immunoassay, ELISA) and 2019-nCoV Nucleic Acid Detec...

2020-02-27 15:47 1913

New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT 2020 KIRKLAND, Washington, Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients ...

2020-02-26 00:50 1165

United Imaging's Emergency Radiology Departments Support Mobile Cabin Hospitals, Facilitate 5G Remote Diagnosis

SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- At the center of the epidemic in Wuhan, many sports centers, exhibition halls, and schools have been turned into mobile cabin hospitals (MCHs) to treat tens of thousands of coronavirus patients with mild symptoms. During the epidemic, fast and accurate CT d...

2020-02-25 21:00 1767

Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China

SUZHOU, China and ROCKVILLE, MD., Feb. 24, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has receive...

2020-02-24 22:00 2422

Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business

SHANGHAI, Feb. 24, 2020 /PRNewswire/ -- Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices. Now they will be able to turn to 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthca...

2020-02-24 16:00 4245

WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

SHANGHAI, Feb. 23, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its strategic partner Immutep, a biotechnology comp...

2020-02-24 08:00 6125

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

AUSTIN, Texas, Feb. 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2019. Volition management will host a conference call tomorrow,February 21, at 8:30 a.m. U.S. Easte...

2020-02-21 05:10 10101

StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...

2020-02-20 20:04 1408

111 Partners with Financial Institutions in Battle Against Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...

2020-02-20 17:00 5333

Ten billion investment to build Chengdu medical city to create a new highland for the international health industry

CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...

2020-02-20 16:04 764
1 ... 205206207208209210211 ... 213